Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

17 Sep 2019 16:41

RNS Number : 6699M
Motif Bio PLC
17 September 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMUBSVRKAAKAAR
Date   Source Headline
30th Sep 20194:35 pmRNSPrice Monitoring Extension
30th Sep 20192:22 pmRNSHalf-year Report
17th Sep 20194:41 pmRNSSecond Price Monitoring Extn
17th Sep 20194:35 pmRNSPrice Monitoring Extension
4th Sep 20192:57 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSAmended Loan and Security Agreement
30th Aug 20194:41 pmRNSSecond Price Monitoring Extn
30th Aug 20194:35 pmRNSPrice Monitoring Extension
19th Aug 20197:00 amRNSNIH to Evaluate Iclaprim Activity against Listeria
1st Aug 20197:00 amRNSAmended Loan and Security Agreement
26th Jul 20197:00 amRNSMotif Bio Confirms Meeting Date with U.S. FDA
26th Jul 20197:00 amRNSReceipt of Deficiency Notice from Nasdaq
19th Jul 20197:00 amRNSMotif Bio-Receipt of Deficiency Notice from Nasdaq
18th Jul 20194:30 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSUS FDA meeting request and package submitted
28th Jun 20195:13 pmRNSHolding(s) in Company
28th Jun 20194:40 pmRNSSecond Price Monitoring Extn
28th Jun 20194:36 pmRNSPrice Monitoring Extension
26th Jun 201912:07 pmRNSSecond Price Monitoring Extn
26th Jun 201912:02 pmRNSPrice Monitoring Extension
24th Jun 20197:00 amRNSMotif Bio Presents New Iclaprim Data - ASM Microbe
20th Jun 20194:35 pmRNSPrice Monitoring Extension
19th Jun 20195:08 pmRNSHolding(s) in Company
18th Jun 20194:05 pmRNSHolding(s) in Company
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20195:52 pmRNSHolding(s) in Company
6th Jun 20197:00 amRNSReceipt of FDA Meeting Minutes
31st May 20193:15 pmRNSResult of AGM
31st May 201910:28 amRNSHolding(s) in Company
29th May 201911:36 amRNSHolding(s) in Company
22nd May 20191:50 pmRNSAGM Statement
22nd May 20197:00 amRNSOrphan Disease Opportunity for Iclaprim
21st May 20197:00 amRNSIclaprim Data presented at ASM Microbe 2019
20th May 20196:14 pmRNSHolding(s) in Company
3rd May 20196:25 pmRNSMeeting with US FDA held as planned
1st May 20197:00 amRNSMotif Signs Agreement with Lamellar Biomedical
26th Apr 20197:01 amRNSNotice of AGM
26th Apr 20197:00 amRNSAppointment of Andrew Powell to Board of Directors
16th Apr 20197:00 amRNSMotif Presents New Iclaprim Data at ECCMID 2019
15th Apr 20197:00 amRNSFiscal Year 2018 Results
4th Apr 20197:00 amRNSMotif Bio to Present Iclaprim Data at ECCMID 2019
2nd Apr 20195:43 pmRNSHolding(s) in Company
1st Apr 20193:28 pmRNSHolding(s) in Company
1st Apr 20192:17 pmRNSHolding(s) in Company
26th Mar 20197:00 amRNSMotif Bio Raises £2.7m (US$3.55m)
25th Mar 20199:49 amRNSProposed Equity Fundraise
20th Mar 20197:00 amRNSHolding(s) in Company
20th Mar 20197:00 amRNSMotif Bio Granted Meeting with U.S. FDA
18th Mar 20197:00 amRNSAppointment of Bruce Williams as Interim Chairman
15th Mar 20197:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.